STOCK TITAN
  1. Home
  2. Sec-filings
  3. TDOC
  4. [Form 4] Teladoc Health, Inc. Insider Trading Activity

Teladoc officer sells 7,573 shares at $6.30

Teladoc Health’s chief legal officer converted vested equity awards into shares and sold a portion to satisfy tax withholding obligations.

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Teladoc Health, Inc. (TDOC) reported insider equity activity by Chief Legal Officer and Secretary Adam C. Vandervoort. On September 1, 2026, his restricted stock units and performance stock units were converted into an aggregate of 14,928 shares of common stock on a one-for-one basis as vesting occurred. On September 2, 2026, he sold 7,573 shares of common stock at $6.301 per share, and a footnote states these shares were sold to cover the tax withholding obligation arising from the vesting of these awards. No Rule 10b5-1 trading plan is reported.

Positive

  • None.

Negative

  • None.
Insider Vandervoort Adam C
Role CHIEF LEGAL OFFICER, SECRETARY
Sold 7,573 shs ($48K)
Approx. gross sale proceeds $48K
Type Security Shares Price Value
Sale Common Stock F3 7,573 $6.301 $48K
Exercise Restricted Stock Units F1, F4 5,350 $0.00 $0.00
Exercise Restricted Stock Units F1, F5 9,152 $0.00 $0.00
Exercise Performance Stock Units F2, F6 426 $0.00 $0.00
Exercise Common Stock F1 5,350 -- --
Exercise Common Stock F1 9,152 -- --
Exercise Common Stock F2 426 -- --
Holdings After Transaction: Restricted Stock Units — 65,618 contracts (Direct); Performance Stock Units — 2,553 contracts (Direct); Common Stock — 117,616 shares (Direct)
Footnotes (6)
  1. F1. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
  2. F2. Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
  3. F3. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
  4. F4. On March 19, 2024, the reporting person was granted 64,200 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
  5. F5. On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  6. F6. On March 1, 2026, the reporting person earned 5,107 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Shares sold 7,573 shares Common stock sale on September 2, 2026
Sale price $6.301 per share Common stock sale on September 2, 2026
Restricted stock units converted (lot 1) 5,350 units Restricted stock units converting one-for-one into common stock on September 1, 2026
Restricted stock units converted (lot 2) 9,152 units Restricted stock units converting one-for-one into common stock on September 1, 2026
Performance stock units converted 426 units Performance stock units converting one-for-one into common stock on September 1, 2026
Total awards converted to common 14,928 shares Aggregate of restricted stock units and performance stock units converting into common stock on September 1, 2026
Performance stock units remaining 2,553 units Reported as credited after the September 1, 2026 performance stock unit transaction
Performance stock units earned 5,107 units Earned on March 1, 2026, vesting one-third immediately and the remainder in installments
Restricted stock units financial
"On March 19, 2024, the reporting person was granted 64,200 restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Performance stock units financial
"Performance stock units convert to shares of TDOC common stock on a one-for-one basis"
Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.
tax withholding obligation financial
"Shares sold to cover the tax withholding obligation in respect of vesting"
vesting financial
"vesting one-third on the first anniversary of the grant date, with the remainder vesting"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

What insider transactions did Teladoc Health (TDOC) report for Adam C. Vandervoort?
Teladoc Health reported that Adam C. Vandervoort had restricted stock units and performance stock units convert into 14,928 shares of common stock on September 1, 2026, and on September 2, 2026 he sold 7,573 shares of common stock.

How many Teladoc Health (TDOC) shares did the insider sell and at what price?
Adam C. Vandervoort sold 7,573 shares of Teladoc Health common stock on September 2, 2026 at a price of $6.301 per share in a reported sale transaction.

Why were 7,573 Teladoc Health (TDOC) shares sold by the insider?
A footnote states the 7,573 shares were sold to cover the tax withholding obligation related to the vesting of Adam C. Vandervoort’s performance stock unit and restricted stock unit awards.

What equity awards for Teladoc Health (TDOC) vested or converted in this Form 4?
On September 1, 2026, 5,350 restricted stock units, 9,152 restricted stock units, and 426 performance stock units each converted into the same number of Teladoc Health common shares on a one-for-one basis as those awards vested.

Were the Teladoc Health (TDOC) insider transactions under a Rule 10b5-1 plan?
The filing’s Rule 10b5-1 checkbox is not marked, and there is no footnote indicating a Rule 10b5-1 or similar pre-arranged trading plan for these transactions.

What performance stock units remain for the Teladoc Health (TDOC) insider after these transactions?
After the September 1, 2026 transaction, the filing reports that 2,553 performance stock units remain credited to Adam C. Vandervoort, each convertible into one share of Teladoc Health common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Vandervoort Adam C
(Last)(First)(Middle)
C/O TELADOC HEALTH, INC.,
155 E 44TH ST, SUITE 1700
(Street)
NEW YORK NEW YORK 10017
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Teladoc Health, Inc. [ TDOC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CHIEF LEGAL OFFICER, SECRETARY
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/01/2026M5,350A(1)115,611D
Common Stock09/01/2026M9,152A(1)124,763D
Common Stock09/01/2026M426A(2)125,189D
Common Stock09/02/2026S7,573(3)D$6.301117,616D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)09/01/2026M5,350 (4) (4)Common Stock5,350$010,700D
Restricted Stock Units(1)09/01/2026M9,152 (5) (5)Common Stock9,152$054,918D
Performance Stock Units(2)09/01/2026M426 (6) (6)Common Stock426$02,553D
Explanation of Responses:
1. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
2. Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
3. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
4. On March 19, 2024, the reporting person was granted 64,200 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
5. On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
6. On March 1, 2026, the reporting person earned 5,107 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Remarks:
/s/ Adam C. Vandervoort09/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR